Volume 102, Issue 10

Search all Annals of Hematology articles

October 2023

38 articles in this issue

Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data
Ferda Can
Keziban Naz Yılmaz
Tekin Güney
Original Article 11 July 2023 Pages: 2645 - 2650
Association between anemia and depression: results from NHANES 2005–2018 and mendelian randomization analyses
Yashan Wang
Dingjie Guo
Xin Liu
Original Article 22 July 2023 Pages: 2651 - 2658
Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions
Vaishali Deenadayalan
Rafaella Litvin
Maryam Zia
Original Article 31 July 2023 Pages: 2659 - 2669
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study
Qunxiang Qiu
Dan Li
Jianchuan Deng
Original Article 18 July 2023 Pages: 2671 - 2682
Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia
Anjali Shah
Chandan Kumar
Babu Rao Vundinti
Original Article 13 July 2023 Pages: 2683 - 2693
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
Wenbing Duan
Sen Yang
Qian Jiang
Original Article 12 August 2023 Pages: 2695 - 2705
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era
Feiyang Qi
Mei Bao
Qian Jiang
Original Article 14 August 2023 Pages: 2707 - 2716
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension
Olga Mulas
Brunella Mola
Giovanni Caocci
Original Article Open access 21 August 2023 Pages: 2717 - 2723
A novel germline hyperactivating JAK2 mutation L604F
Lukáš Dvořáček
Jana Marková
Jiří Schwarz
Original Article Open access 28 August 2023 Pages: 2725 - 2734
Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
Andrea Corbingi
Rossana Putzulu
Nicola Piccirillo
Original Article 17 August 2023 Pages: 2735 - 2740
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
Susanne Isfort
Kirsi Manz
for the German CML study group
Original Article Open access 18 August 2023 Pages: 2741 - 2752
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Ethan A. Burns
Justin J. Wilson
Sai Ravi Pingali
Original Article 08 July 2023 Pages: 2753 - 2763
A prediction model for severe hematological toxicity of BTK inhibitors
Dan Jiang
Zaiwei Song
Rongsheng Zhao
Original Article 25 July 2023 Pages: 2765 - 2777
Role of body composition and metabolic parameters extracted from baseline ¹⁸F-FDG PET/CT in patients with diffuse large B-cell lymphoma
Yang Chen
Zhijian Chen
Lei Jiang
Original Article 02 August 2023 Pages: 2779 - 2789
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
Luca Fischer
Linmiao Jiang
on behalf of the German Lymphoma Alliance (GLA) and the German Low-Grade Lymphoma Study Group (GLSG)
Original Article Open access 08 August 2023 Pages: 2791 - 2801
Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series
Yue-Hua Zhang
Zheng Li
Li-Min Gao
Original Article 12 July 2023 Pages: 2803 - 2813
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
Lilian Goveia
Nelson Castro
Irene Biasoli
Original Article 21 July 2023 Pages: 2815 - 2822
Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma
Agurne García-Baztán
Mari Cruz Viguria-Alegria
Julio Oteiza-Olaso
Original Article 11 August 2023 Pages: 2823 - 2834
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India
Nirmalya Roy Moulik
Swaminathan Keerthivasagam
Shripad Banavali
Original Article 21 July 2023 Pages: 2835 - 2844
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma
Chen Gong
Jiazhuo Wu
Mingzhi Zhang
Original Article 27 July 2023 Pages: 2845 - 2855
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease
Qing He
Xuelin Dou
Jin Lu
Original Article 12 July 2023 Pages: 2857 - 2864
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
Jiapei Liu
Zhiping Fan
Hua Jin
Original Article 20 July 2023 Pages: 2865 - 2877
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
Hiroaki Araie
Yasuyuki Arai
for the Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy
Original Article Open access 21 July 2023 Pages: 2879 - 2893
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial
Naoki Kurita
Hidekazu Nishikii
Shigeru Chiba
Original Article 17 August 2023 Pages: 2895 - 2902
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
Anjali Cremer
Julius C. Enssle
Gesine Bug
Original Article Open access 08 August 2023 Pages: 2903 - 2908
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
Tomoki Iemura
Tadakazu Kondo
Akifumi Takaori-Kondo
Original Article 13 April 2023 Pages: 2909 - 2922
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region
Alessia Sticchi Damiani
Antonella Zizza
The Seroprevalence COVID Blood Donors Study Group
Original Article Open access 13 July 2023 Pages: 2923 - 2931
Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis
Xinyue Chen
Juan Xiao
Weiwei Tian
Original Article 08 July 2023 Pages: 2933 - 2942
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
Mengru Tian
Xinyue Liang
Fengyan Jin
Letter to the Editor 12 July 2023 Pages: 2943 - 2945
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3
Yukiko Komeno
Toru Uchiyama
Akira Ishiguro
Letter to the Editor 29 July 2023 Pages: 2947 - 2949
Successful treatment of systemic mastocytosis with acute myeloid leukemia: a case report
Minran Zhou
Guangcai Zhong
Chunyan Chen
Letter to the Editor 11 July 2023 Pages: 2951 - 2953
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
Jian Li
Chunyan Cao
Yongjun Fang
Letter to the Editor 25 July 2023 Pages: 2955 - 2957
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
Toyoshi Yanagihara
Kentaro Hata
Isamu Okamoto
Letter to the Editor 31 July 2023 Pages: 2959 - 2961
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
Alice Di Rocco
Martina Di Palma
Maurizio Martelli
Letter to the Editor 19 July 2023 Pages: 2963 - 2964
Real-life experience with luspatercept in transfusion-dependent β-thalassemia
Daniela Roccotelli
Domenica Grande
Pellegrino Musto
Letter to the Editor 27 July 2023 Pages: 2965 - 2967
One disease, two faces: clonally-related AML and MPDCP with skin involvement
Giovanni Martino
Gaetano Cimino
Maria Paola Martelli
Letter to the Editor 22 July 2023 Pages: 2969 - 2971
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases
Yupeng Wang
Zi Wang
Daobin Zhou
Letter to the Editor 31 July 2023 Pages: 2973 - 2975
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma
A. Rago
G. Palumbo
T. Caravita di Toritto
Letter to the Editor 11 July 2023 Pages: 2977 - 2978

Volume 102, Issue 10

Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data

Association between anemia and depression: results from NHANES 2005–2018 and mendelian randomization analyses

Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions

Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study

Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia

Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia

Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era

Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension

A novel germline hyperactivating JAK2 mutation L604F

Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?

Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry

A prediction model for severe hematological toxicity of BTK inhibitors

Role of body composition and metabolic parameters extracted from baseline ¹⁸F-FDG PET/CT in patients with diffuse large B-cell lymphoma

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis

Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series

Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry

Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma

Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India

Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma

Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease

Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy

Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan

Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region

Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis

More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma

Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3

Successful treatment of systemic mastocytosis with acute myeloid leukemia: a case report

Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation

Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung

Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?

Real-life experience with luspatercept in transfusion-dependent β-thalassemia

One disease, two faces: clonally-related AML and MPDCP with skin involvement

Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases

A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma

Navigation